» Articles » PMID: 29411144

Olfactory Neuroblastoma

Overview
Journal Curr Oncol Rep
Publisher Current Science
Specialty Oncology
Date 2018 Feb 8
PMID 29411144
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: To provide a comprehensive review of the literature focusing on the recent advances in the diagnosis and management of olfactory neuroblastoma.

Recent Findings: Multimodality treatment is usually recommended for the majority of ONB cases. Recent advances in surgical approaches include the evolving role of endonasal endoscopic surgical resection and reconstruction. The introduction of new conformal radiation techniques has improved the outcomes and reduced treatment-related toxicity to important structures such as the eye and the brain. The role of neoadjuvant and adjuvant chemotherapy is yet to be defined. In the last two decades, there have been advances in surgical techniques with endoscopic approaches, either alone or in combination with craniotomy, gradually replacing the open traditional approaches. Prolonged surveillance is recommended for ONB due to late recurrences associated with that tumor. The role of chemotherapy and elective neck irradiation is still controversial and needs more studies to investigate their optimal role.

Citing Articles

An Uncommon Encounter: Metastatic Olfactory Neuroblastoma in an Adult Male.

Kalfoutzou A, Restemi A, Rapti C, Chaleplidis N, Bagiokou E, Bartzi D Cureus. 2024; 16(11):e73105.

PMID: 39650873 PMC: 11621874. DOI: 10.7759/cureus.73105.


Single-cell transcriptomic landscape deciphers olfactory neuroblastoma subtypes and intra-tumoral heterogeneity.

Yang J, Song X, Zhang H, Liu Q, Wei R, Guo L Nat Cancer. 2024; 5(12):1919-1939.

PMID: 39543363 DOI: 10.1038/s43018-024-00855-5.


Endoscopy-assisted medial canthus incision for olfactory neuroblastoma: a case report.

Li Y, Zhao X, Tao Y World J Surg Oncol. 2024; 22(1):163.

PMID: 38909260 PMC: 11193278. DOI: 10.1186/s12957-024-03448-9.


Olfactory Neuroblastoma Causing Cushing's Syndrome Due to the Ectopic Adrenocorticotropic Hormone (ACTH) Secretion: A Case Report.

Alsarari A, Abdulkader A, Farooqi W, Al-Shibani S, Al Khuwaitir T Cureus. 2024; 16(3):e56434.

PMID: 38638776 PMC: 11024664. DOI: 10.7759/cureus.56434.


A case of olfactory neuroblastoma that presented with olfactory dysfunction after a COVID-19 diagnosis.

Kim K, Min H Heliyon. 2023; 9(11):e22311.

PMID: 38053881 PMC: 10694305. DOI: 10.1016/j.heliyon.2023.e22311.


References
1.
Morita A, Ebersold M, Olsen K, Foote R, Lewis J, Quast L . Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993; 32(5):706-14; discussion 714-5. DOI: 10.1227/00006123-199305000-00002. View

2.
Demiroz C, Gutfeld O, Aboziada M, Brown D, Marentette L, Eisbruch A . Esthesioneuroblastoma: is there a need for elective neck treatment?. Int J Radiat Oncol Biol Phys. 2011; 81(4):e255-61. DOI: 10.1016/j.ijrobp.2011.03.036. View

3.
Lund V, Howard D, Wei W, Spittle M . Olfactory neuroblastoma: past, present, and future?. Laryngoscope. 2003; 113(3):502-7. DOI: 10.1097/00005537-200303000-00020. View

4.
Plasencia Y, Boronat Cortes M, Marrero Arencibia D, Montenegro Damaso T, Contreras I, Ojeda Pino A . Esthesioneuroblastoma recurrence presenting as a syndrome of inappropriate antidiuretic hormone secretion. Head Neck. 2006; 28(12):1142-6. DOI: 10.1002/hed.20352. View

5.
Nishimura H, Ogino T, Kawashima M, Nihei K, Arahira S, Onozawa M . Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys. 2007; 68(3):758-62. DOI: 10.1016/j.ijrobp.2006.12.071. View